General MedicationsVIALStandard
PULMOZYME
DORNASE ALFA
Standard Dose
1MG/ML
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Prescription
Summary
Approval overview PULMOZYME is listed in Drugs@FDA under application 103532 (BLA).
Review priority: STANDARD Marketing status: Prescription Active ingredient DORNASE ALFA Form and strength VIAL - 1MG/ML Sponsor GENENTECH Submission history Latest submission status date: 2024-02-09 00:00:00.
Structured Monograph
Clinical summary
Approval overview PULMOZYME is listed in Drugs@FDA under application 103532 (BLA). Review priority: STANDARD Marketing status: Prescription Active ingredient DORNASE ALFA Form and strength VIAL - 1MG/ML Sponsor GENENTECH Submission history Latest submission status date: 2024-02-09 00:00:00. Submission type: SUPPL.
Monitoring
- • Marketing status: Prescription
- • Review priority: STANDARD
Interaction Notes
- No interaction notes stored yet.